GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VitaSpring Biomedical Co Ltd (OTCPK:VSBC) » Definitions » Net Margin %

VSBC (VitaSpring Biomedical Co) Net Margin % : 0.00% (As of Oct. 2022)


View and export this data going back to 2019. Start your Free Trial

What is VitaSpring Biomedical Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. VitaSpring Biomedical Co's Net Income for the three months ended in Oct. 2022 was $-0.14 Mil. VitaSpring Biomedical Co's Revenue for the three months ended in Oct. 2022 was $0.00 Mil. Therefore, VitaSpring Biomedical Co's net margin for the quarter that ended in Oct. 2022 was 0.00%.

The historical rank and industry rank for VitaSpring Biomedical Co's Net Margin % or its related term are showing as below:


VSBC's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -109.01
* Ranked among companies with meaningful Net Margin % only.

VitaSpring Biomedical Co Net Margin % Historical Data

The historical data trend for VitaSpring Biomedical Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VitaSpring Biomedical Co Net Margin % Chart

VitaSpring Biomedical Co Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22
Net Margin %
Get a 7-Day Free Trial -37.50 -129.41 46.67 -171.37 22.52

VitaSpring Biomedical Co Quarterly Data
Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -68.50 26.97 18.59 - -

Competitive Comparison of VitaSpring Biomedical Co's Net Margin %

For the Biotechnology subindustry, VitaSpring Biomedical Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VitaSpring Biomedical Co's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VitaSpring Biomedical Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where VitaSpring Biomedical Co's Net Margin % falls into.


;
;

VitaSpring Biomedical Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

VitaSpring Biomedical Co's Net Margin for the fiscal year that ended in Jan. 2022 is calculated as

Net Margin=Net Income (A: Jan. 2022 )/Revenue (A: Jan. 2022 )
=1.264/5.613
=22.52 %

VitaSpring Biomedical Co's Net Margin for the quarter that ended in Oct. 2022 is calculated as

Net Margin=Net Income (Q: Oct. 2022 )/Revenue (Q: Oct. 2022 )
=-0.138/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


VitaSpring Biomedical Co  (OTCPK:VSBC) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


VitaSpring Biomedical Co Net Margin % Related Terms

Thank you for viewing the detailed overview of VitaSpring Biomedical Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


VitaSpring Biomedical Co Business Description

Traded in Other Exchanges
N/A
Address
400 Spectrum Center Dr. No. 1620, Irvine, CA, USA, 92618
VitaSpring Biomedical Co Ltd is a start-up business company. The company's objective is to develop new drugs in cell medicine. The company also plans to produce X.MSC cytopharmaceuticals.

VitaSpring Biomedical Co Headlines

No Headlines